CHS Inc. Files 8-K Report
Ticker: CHSCO · Form: 8-K · Filed: Mar 29, 2024
Sentiment: neutral
Topics: disclosure, financials
TL;DR
CHS Inc. filed an 8-K, mostly standard financial disclosures.
AI Summary
On March 29, 2024, CHS Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD Disclosure. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This filing indicates that CHS Inc. is providing updated financial information and disclosures to the SEC, which is standard practice for public companies.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial statements and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- CHS Inc. (company) — Registrant
- 0000823277-24-000011.txt (document) — Filing document name
- March 29, 2024 (date) — Report date
FAQ
What is the purpose of this 8-K filing by CHS Inc.?
The 8-K filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on financial statements and exhibits, and including a Regulation FD Disclosure.
What is the exact name of the registrant?
The exact name of the registrant is CHS Inc.
On what date was this report filed or is it effective?
The date of the report, and the earliest event reported, is March 29, 2024.
What is the Commission File Number for CHS Inc.?
The Commission File Number for CHS Inc. is 001 - 36079.
In which state is CHS Inc. incorporated?
CHS Inc. is incorporated in Minnesota.
Filing Stats: 591 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-03-29 10:30:23
Filing Documents
- chscp-20240329.htm (8-K) — 38KB
- 0000823277-24-000011.txt ( ) — 218KB
- chscp-20240329.xsd (EX-101.SCH) — 4KB
- chscp-20240329_def.xml (EX-101.DEF) — 16KB
- chscp-20240329_lab.xml (EX-101.LAB) — 31KB
- chscp-20240329_pre.xml (EX-101.PRE) — 17KB
- chscp-20240329_htm.xml (XML) — 6KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. In January 2024, CHS Inc. (" CHS") and Growmark, Inc. (" GROWMARK ") entered an exploratory process to identify opportunities for the two companies to further collaborate. That exploratory process has concluded, and it has been determined that no new opportunities will be pursued at this time. CHS and GROWMARK will continue to serve their respective owners by maintaining their current partnerships and continuing to function as two independent cooperatives. Pursuant to General Instruction B.2. to Form 8–K, the information set forth in this Item 7.01 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. In addition, the information set forth in this Item 7.01 shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall otherwise be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHS Inc. Date: March 29, 2024 By: /s/ Olivia Nelligan Olivia Nelligan Executive Vice President, Chief Financial Officer and Chief Strategy Officer